Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma

Completed · Phase 2

Conditions studied: Melanoma (Skin)

In brief

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop tumor cells from growing. Combining biological therapies with indomethacin and cyclophosphamide may kill more tumor cells. PURPOSE: Phase II trial to compare the effectiveness of indomethacin and biological therapy with or without cyclophosphamide in treating patients who have advanced melanoma that has not responded to previous therapy.

Key facts

Study ID

NCT00002535

Run by

St. Luke's Medical Center

Starts

1993-07-01

Expected to finish

2004-07-01

Last updated by the study team

2013-06-26

Who can join

Age: 17 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• St. Luke's Medical Center — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.